Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines.
- DOI
- 10.3390/cancers12030577
- Published
- 2020 Mar 2
- Container
- Cancers
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers12030577,
title = {Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines.},
author = {Michaelis M and Voges Y and Rothweiler F and Weipert F and Zia-Ahmad A and Cinatl J and von Deimling A and Westermann F and Rödel F and Wass MN and Cinatl J Jr},
year = {2020},
journal = {Cancers},
doi = {10.3390/cancers12030577},
url = {https://doi.org/10.3390/cancers12030577}
}RIS
TY - JOUR TI - Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines. AU - Michaelis M AU - Voges Y AU - Rothweiler F AU - Weipert F AU - Zia-Ahmad A AU - Cinatl J AU - von Deimling A AU - Westermann F AU - Rödel F AU - Wass MN AU - Cinatl J Jr PY - 2020 JO - Cancers DO - 10.3390/cancers12030577 UR - https://doi.org/10.3390/cancers12030577 ER -
APA
M, M., Y, V., F, R., F, W., A, Z., J, C., A, V. D., F, W., F, R., MN, W., & Jr, C. J. (2020). Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines.. Cancers. https://doi.org/10.3390/cancers12030577
Source records
- pubmed · retrieved 2026-09-27T13:17:43.996Z